Načítá se...
Flow Cytometric Immune Profiling in Infliximab-Associated Tuberculosis
Tumor necrosis factor α antagonists are increasingly used to treat inflammatory and autoimmune disorders and are associated with increased risk of active tuberculosis. Diagnosis of active tuberculosis in patients taking tumor necrosis factor α antagonists can be challenging owing to increased incide...
Uloženo v:
| Vydáno v: | Clin Med Insights Case Rep |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
SAGE Publications
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5574471/ https://ncbi.nlm.nih.gov/pubmed/28890660 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1179547617724776 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|